Lipid peroxidation and resistance to oxidation in patients with type 2 diabetes mellitus

The Tohoku Journal of Experimental Medicine
Hatice PasaogluNeslihan Bukan

Abstract

We investigated lipid peroxidation, resistance of plasma and red blood cells to oxidation, and antioxidant defense system in erythrocytes and sera in patients with type 2 diabetes mellitus. One group included newly diagnosed 20 patients and the other included 20 patients treated with oral antidiabetic agents (OAD). Twenty healthy subjects served as controls. Serum and red blood cell malondialdehyde (MDA), glutathione (GSH), resistance to oxidation, and plasma thiol (total -SH) levels were measured. In addition, glycated hemoglobin, serum fructosamine, uric acid, total protein, total cholesterol, triglyceride and glucose levels were determined. Although newly diagnosed patients had higher serum and erythrocyte MDA levels than those of controls, the highest levels of MDA were determined in patients treated with OAD. MDA levels after exposing to oxidation increased in OAD group more than in newly diagnosed patients. Total -SH and erythrocyte GSH levels of the both diabetic groups were lower than controls. These results show that serum and erythrocyte lipid peroxidation was increased in diabetic patients. The sera of the patients showed a decreased resistance against oxidation. We therefore suggest that the effect of increased free...Continue Reading

References

Jun 1, 1979·Analytical Biochemistry·H OhkawaK Yagi
Nov 15, 1978·Clinica Chimica Acta; International Journal of Clinical Chemistry·K Satoh
Jan 1, 1992·Free Radical Research Communications·A B BridgesJ J Belch
Jan 1, 1990·Diabetic Medicine : a Journal of the British Diabetic Association·A CollierM Small
Jan 1, 1990·Free Radical Research Communications·B Halliwell
Jan 1, 1986·The Journal of Membrane Biology·S Bannai, N Tateishi
Sep 1, 1974·Clinical Science and Molecular Medicine·J StocksT L Dormandy
Apr 25, 1983·Clinica Chimica Acta; International Journal of Clinical Chemistry·J C DoussetM J Foglietti
Nov 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·B N AmesP Hochstein
Aug 1, 1995·Free Radical Biology & Medicine·L PackerH J Tritschler
Feb 28, 1993·Clinica Chimica Acta; International Journal of Clinical Chemistry·G GallouL Cloarec
Mar 1, 1996·Diabetes Care·D GiuglianoG Paolisso
Dec 9, 1997·The British Journal of Nutrition·J H BatesD R Hadden
Dec 23, 1998·Biochemistry and Molecular Biology International·R S RichardsH L Butt
Jan 5, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·A Y Lee, S S Chung
Feb 11, 1999·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·E BourdonD Blache
Dec 22, 1999·Metabolism: Clinical and Experimental·D KonukoğluH Hatemi
Apr 1, 2000·Research in Experimental Medicine. Zeitschrift Für Die Gesamte Experimentelle Medizin Einschliesslich Experimenteller Chirurgie·U CakatayT Akçay
Dec 7, 2000·Diabetes Research and Clinical Practice·A TelciA Sivas
Apr 3, 2001·Clinica Chimica Acta; International Journal of Clinical Chemistry·P M Abuja, R Albertini
May 29, 2002·Clinica Chimica Acta; International Journal of Clinical Chemistry·Ilham SeghrouchniAndré Revol
Jun 28, 2002·Free Radical Biology & Medicine·Birgit WittensteinAlfried Kohlschütter
Mar 20, 2003·Current Diabetes Reports·Bibi Hasanain, Arshag D Mooradian

❮ Previous
Next ❯

Citations

Mar 1, 2007·Indian Journal of Clinical Biochemistry : IJCB·Y S MahindrakarK M Kumbhar
Apr 2, 2005·The Tohoku Journal of Experimental Medicine·Mustafa GulMehmet Akif Buyukbese
Jan 5, 2007·The Tohoku Journal of Experimental Medicine·Gülsen YilmazDogan Yücel
Dec 14, 2007·The Tohoku Journal of Experimental Medicine·Y Gül OzkayaPiraye Yargiçoğlu
Mar 3, 2007·Journal of Nutritional Science and Vitaminology·Eun Ju ChoTakako Yokozawa
Feb 7, 2013·International Journal of Molecular Sciences·Suziy de M BandeiraSandra Mary L Vasconcelos
Oct 10, 2007·Acta Diabetologica·Vadde Ramakrishna, Rama Jailkhani
Feb 11, 2015·Chemico-biological Interactions·Marcia C da Silva FariaAntonio Cardozo Dos Santos
Mar 25, 2008·Journal of Diabetes and Its Complications·Tatjana CvetkovićVladisav Stefanović
Jan 18, 2015·Acta neurologica Belgica·Yasemin ErenÖzcan Erel
Mar 26, 2009·Journal of Pineal Research·Kornelia Kedziora-KornatowskaJózef Kedziora
Sep 17, 2011·Andrologia·S La VigneraA E Calogero
Feb 9, 2012·Cell Biochemistry and Function·Noha Ahmed El Boghdady, Gamal Ali Badr
Mar 25, 2010·Journal of Clinical Laboratory Analysis·Fatma Meriç YilmazDoğan Yücel
Mar 15, 2013·Redox Report : Communications in Free Radical Research·Octavian SavuIrina Stoian
Oct 19, 2016·Saudi Pharmaceutical Journal : SPJ : the Official Publication of the Saudi Pharmaceutical Society·Ullah AsmatKhan Ismail
Mar 3, 2015·Diabetes Research and Clinical Practice·R SauriasariK Ogino
Apr 3, 2007·Journal of Pediatric Endocrinology & Metabolism : JPEM·Fatma Meriç YilmazDogan Yücel
May 2, 2017·Journal of Cellular Biochemistry·Kanwal Rehman, Muhammad Sajid Hamid Akash
Dec 19, 2006·Chemical Research in Toxicology·Jingmin Zeng, Michael J Davies

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.